FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1538807185> ?p ?o ?g. }

• W1538807185 endingPage "1526" @default.
• W1538807185 startingPage "1520" @default.
• W1538807185 abstract "OBJECTIVE • To conduct a preclinical evaluation of the ability of natural killer cells to cytolyze bladder cancer cells that were modified to show enhanced expression of natural‐killer group 2, member D (NKG2D) ligands by R8‐liposome‐bacillus Calmette‐Guéin (BCG)‐cell wall skeleton (CWS) treatment. MATERIALS AND METHODS • The T24 cells and RT‐112 cells were co‐cultured with R8‐liposome‐BCG‐CWS and BCG for 2, 4, or 6 h, and then the surface expression of NKG2D ligands was analyzed using TaqMan real‐time quantitative RT‐PCR. • Peripheral blood mononuclear cells were obtained with a conventional preparation kit, and then lymphokine‐activated killer (LAK) cells were generated from these purified peripheral blood mononuclear cells via interleukin‐2 stimulation. • The anti‐tumour effect of LAK cells against untreated and R8‐liposome‐BCG‐CWS co‐cultured with cells of the human bladder cancer cell lines T24 and RT‐112 was analyzed using the cytotoxic WST‐8 assay method at 4 h of culture at various effector/target (E : T) ratios. RESULTS • Major histocompatibility complex class I‐related chain B (MICB) expression was increased ≈1.5‐fold on T24 cells and RT‐112 cells with BCG. • UL‐16‐binding protein (ULBP) 1 expression was also increased ≈1.5‐fold on T24 cells and RT‐112 cells with BCG. R8‐liposome‐BCG‐CWS increased the surface expression of MICB 2.2‐fold on T24 cells but did not increase it significantly on RT‐112 cells. • ULBP1 expression was increased ≈2.2‐fold on RT‐112 cells, although no differences were observed between the expression of ULBP2 and 3 with R8‐liposome‐BCG‐CWS. • T24 cells that were co‐cultured with R8‐liposome‐BCG‐CWS showed an ≈1.3‐fold increase in sensitivity to cytolysis by LAK cells at an E : T ratio of 4 and RT‐112 cells showed an ≈1.4‐fold increase at an E : T ratio of 2. CONCLUSIONS • In the present study, the induction of surface NKG2D ligands by R8‐liposome‐BCG‐CWS rendered cancer cells more susceptible to cytolysis by LAK cells. • T24 cells and RT‐112 cells, even when cultured singly in the absence of immune cells, can directly respond to R8‐liposome‐BCG‐CWS. • The results obtained in the present study may therefore indicate a novel adoptive immunotherapy against bladder cancers." @default.
• W1538807185 created "2016-06-24" @default.
• W1538807185 creator A5001660113 @default.
• W1538807185 creator A5005444655 @default.
• W1538807185 creator A5006918664 @default.
• W1538807185 creator A5010547620 @default.
• W1538807185 creator A5018595267 @default.
• W1538807185 creator A5047716545 @default.
• W1538807185 creator A5050249881 @default.
• W1538807185 creator A5056993350 @default.
• W1538807185 creator A5069020781 @default.
• W1538807185 creator A5081191749 @default.
• W1538807185 creator A5085712245 @default.
• W1538807185 date "2011-02-11" @default.
• W1538807185 modified "2023-10-18" @default.
• W1538807185 title "The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands" @default.
• W1538807185 cites W1500432626 @default.
• W1538807185 cites W1502407336 @default.
• W1538807185 cites W1532737852 @default.
• W1538807185 cites W182727707 @default.
• W1538807185 cites W1974752722 @default.
• W1538807185 cites W1983608025 @default.
• W1538807185 cites W1987107156 @default.
• W1538807185 cites W1993786192 @default.
• W1538807185 cites W1993885753 @default.
• W1538807185 cites W1995189245 @default.
• W1538807185 cites W1997103748 @default.
• W1538807185 cites W1999191024 @default.
• W1538807185 cites W1999341606 @default.
• W1538807185 cites W2007826451 @default.
• W1538807185 cites W2009857031 @default.
• W1538807185 cites W2010960852 @default.
• W1538807185 cites W2014075623 @default.
• W1538807185 cites W2016840392 @default.
• W1538807185 cites W2018664504 @default.
• W1538807185 cites W2019214729 @default.
• W1538807185 cites W2024579897 @default.
• W1538807185 cites W2034558707 @default.
• W1538807185 cites W2038588202 @default.
• W1538807185 cites W2039808506 @default.
• W1538807185 cites W2050672174 @default.
• W1538807185 cites W2051650552 @default.
• W1538807185 cites W2056962754 @default.
• W1538807185 cites W2064920472 @default.
• W1538807185 cites W2080918383 @default.
• W1538807185 cites W2084292672 @default.
• W1538807185 cites W2091814508 @default.
• W1538807185 cites W2097641815 @default.
• W1538807185 cites W2107277218 @default.
• W1538807185 cites W2109604006 @default.
• W1538807185 cites W2130443822 @default.
• W1538807185 cites W2170069789 @default.
• W1538807185 cites W2174493400 @default.
• W1538807185 cites W2409438189 @default.
• W1538807185 cites W2444471592 @default.
• W1538807185 doi "https://doi.org/10.1111/j.1464-410x.2010.10056.x" @default.
• W1538807185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21314815" @default.
• W1538807185 hasPublicationYear "2011" @default.
• W1538807185 type Work @default.
• W1538807185 sameAs 1538807185 @default.
• W1538807185 citedByCount "13" @default.
• W1538807185 countsByYear W15388071852013 @default.
• W1538807185 countsByYear W15388071852014 @default.
• W1538807185 countsByYear W15388071852015 @default.
• W1538807185 countsByYear W15388071852016 @default.
• W1538807185 countsByYear W15388071852017 @default.
• W1538807185 countsByYear W15388071852018 @default.
• W1538807185 countsByYear W15388071852019 @default.
• W1538807185 countsByYear W15388071852020 @default.
• W1538807185 countsByYear W15388071852022 @default.
• W1538807185 crossrefType "journal-article" @default.
• W1538807185 hasAuthorship W1538807185A5001660113 @default.
• W1538807185 hasAuthorship W1538807185A5005444655 @default.
• W1538807185 hasAuthorship W1538807185A5006918664 @default.
• W1538807185 hasAuthorship W1538807185A5010547620 @default.
• W1538807185 hasAuthorship W1538807185A5018595267 @default.
• W1538807185 hasAuthorship W1538807185A5047716545 @default.
• W1538807185 hasAuthorship W1538807185A5050249881 @default.
• W1538807185 hasAuthorship W1538807185A5056993350 @default.
• W1538807185 hasAuthorship W1538807185A5069020781 @default.
• W1538807185 hasAuthorship W1538807185A5081191749 @default.
• W1538807185 hasAuthorship W1538807185A5085712245 @default.
• W1538807185 hasConcept C121608353 @default.
• W1538807185 hasConcept C126322002 @default.
• W1538807185 hasConcept C129374314 @default.
• W1538807185 hasConcept C137061746 @default.
• W1538807185 hasConcept C139563560 @default.
• W1538807185 hasConcept C149532602 @default.
• W1538807185 hasConcept C153911025 @default.
• W1538807185 hasConcept C154317977 @default.
• W1538807185 hasConcept C167672396 @default.
• W1538807185 hasConcept C202751555 @default.
• W1538807185 hasConcept C203014093 @default.
• W1538807185 hasConcept C2778867473 @default.
• W1538807185 hasConcept C28651165 @default.
• W1538807185 hasConcept C55493867 @default.
• W1538807185 hasConcept C71924100 @default.
• W1538807185 hasConcept C86803240 @default.

• next